Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C20H27NO3.ClH |
| Molecular Weight | 365.894 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCNCC#CCOC(=O)C(O)(C1CCCCC1)C2=CC=CC=C2
InChI
InChIKey=DSWCYTSHCYXHGW-UHFFFAOYSA-N
InChI=1S/C20H27NO3.ClH/c1-2-21-15-9-10-16-24-19(22)20(23,17-11-5-3-6-12-17)18-13-7-4-8-14-18;/h3,5-6,11-12,18,21,23H,2,4,7-8,13-16H2,1H3;1H
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Effect of 4-ethylamino-2-butynyl(2-cyclohexyl-2-phenyl) glycolate, metabolite of oxybutynin, on intra-artery administered acetylcholine-induced urinary bladder contraction in anesthetized dogs]. | 2004-05 |
|
| Effects of 4-ethylamino-2-butynyl(2-cyclohexyl-2-phenyl)glycolate hydrochloride, a metabolite of oxybutynin, on bladder specimens and rhythmic bladder contraction in rats in comparison with oxybutynin. | 2004-02 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
HD6V2A9QPV
Created by
admin on Wed Apr 02 04:13:55 GMT 2025 , Edited by admin on Wed Apr 02 04:13:55 GMT 2025
|
PRIMARY | |||
|
9842085
Created by
admin on Wed Apr 02 04:13:55 GMT 2025 , Edited by admin on Wed Apr 02 04:13:55 GMT 2025
|
PRIMARY | |||
|
81039-77-2
Created by
admin on Wed Apr 02 04:13:55 GMT 2025 , Edited by admin on Wed Apr 02 04:13:55 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
